doi: 10.1039/b300527e.
Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients
Affiliations
- PMID: 12705377
- DOI: 10.1039/b300527e
Item in Clipboard
Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients
Analyst.
2003 Mar.
Abstract
A sensitive, accurate and specific method for the analysis of antimony by ICP-MS is presented as a marker of the sentinel lymph node in melanoma patients.
Similar articles
-
Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry.Ann Surg Oncol. 2008 Mar;15(3):934-40. doi: 10.1245/s10434-007-9693-0. Epub 2008 Jan 3. Ann Surg Oncol. 2008. PMID: 18172734 Free PMC article.
-
Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients.Ann Surg Oncol. 2004 Mar;11(3 Suppl):174S-8S. doi: 10.1007/BF02523624. Ann Surg Oncol. 2004. PMID: 15023747
-
Correct identification of a sentinel node postselective lymphadenectomy using antimony levels.Melanoma Res. 2008 Oct;18(5):365-6. doi: 10.1097/CMR.0b013e328307bf2d. Melanoma Res. 2008. PMID: 18781136
-
Pathobiology of the sentinel node.Curr Opin Oncol. 2008 Mar;20(2):190-5. doi: 10.1097/CCO.0b013e3282f46d70. Curr Opin Oncol. 2008. PMID: 18300769 Review.
-
Long-term clinical impact of sentinel lymph node biopsy in breast cancer and cutaneous melanoma.Q J Nucl Med Mol Imaging. 2014 Jun;58(2):95-104. Q J Nucl Med Mol Imaging. 2014. PMID: 24835286 Review.
Cited by
-
Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry.Ann Surg Oncol. 2008 Mar;15(3):934-40. doi: 10.1245/s10434-007-9693-0. Epub 2008 Jan 3. Ann Surg Oncol. 2008. PMID: 18172734 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
